↑Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, et al. (2007). "The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells". J Cell Physiol. 213 (2): 511–8. doi:10.1002/jcp.21133. PMID17503467.
Further reading
Guan Y, Kuo WL, Stilwell JL, et al. (2007). "Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer". Clin. Cancer Res. 13 (19): 5745–55. doi:10.1158/1078-0432.CCR-06-2882. PMID17908964.
Millis MP, Bowen D, Kingsley C, et al. (2007). "Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes". Diabetes. 56 (12): 3027–32. doi:10.2337/db07-0675. PMID17881614.
Carramusa L, Contino F, Ferro A, et al. (2008). "The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells". J. Cell. Physiol. 213 (2): 511–8. doi:10.1002/jcp.21133. PMID17503467.
Hanson RL, Craig DW, Millis MP, et al. (2007). "Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study". Diabetes. 56 (4): 975–83. doi:10.2337/db06-1072. PMID17395743.
Oh JH, Yang JO, Hahn Y, et al. (2006). "Transcriptome analysis of human gastric cancer". Mamm. Genome. 16 (12): 942–54. doi:10.1007/s00335-005-0075-2. PMID16341674.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.